NONISOTOPIC HYBRIDIZATION ASSAY FOR DETERMINATION OF RELATIVE AMOUNTS OF GENOTYPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ZIDOVUDINE RESISTANCE

被引:19
作者
EASTMAN, PS [1 ]
BOYER, E [1 ]
MOLE, L [1 ]
KOLBERG, J [1 ]
URDEA, M [1 ]
HOLODNIY, M [1 ]
机构
[1] VET AFFAIRS MED CTR,CTR AIDS RES,PALO ALTO,CA 94304
关键词
D O I
10.1128/JCM.33.10.2777-2780.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A nonisotopic hybridization assay for human immunodeficiency virus genotypic zidovudine resistance determination is described. Biotinylated PCR product was hybridized with enzyme labeled probes for,wild-type or resistant mutant sequences and detected colorimetrically or chemiluminescently in a microplate format. Changes in mutant-to-wild-type ratios allow for the monitoring of longitudinal patient samples.
引用
收藏
页码:2777 / 2780
页数:4
相关论文
共 15 条
[1]   HIV-1 BIOLOGICAL PHENOTYPE AND THE DEVELOPMENT OF ZIDOVUDINE RESISTANCE IN RELATION TO DISEASE PROGRESSION IN ASYMPTOMATIC INDIVIDUALS DURING TREATMENT [J].
BOUCHER, CAB ;
LANGE, JMA ;
MIEDEMA, FF ;
WEVERLING, GJ ;
KOOT, M ;
MULDER, JW ;
GOUDSMIT, J ;
KELLAM, P ;
LARDER, BA ;
TERSMETTE, M .
AIDS, 1992, 6 (11) :1259-1264
[2]   GENETIC-RECOMBINATION OF HUMAN IMMUNODEFICIENCY VIRUS [J].
CLAVEL, F ;
HOGGAN, MD ;
WILLEY, RL ;
STREBEL, K ;
MARTIN, MA ;
REPASKE, R .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1455-1459
[3]   ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY [J].
DAQUILA, RT ;
JOHNSON, VA ;
WELLES, SL ;
JAPOUR, AJ ;
KURITZKES, DR ;
DEGRUTTOLA, V ;
REICHELDERFER, PS ;
COOMBS, RW ;
CRUMPACKER, CS ;
KAHN, JO ;
RICHMAN, DD .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) :401-408
[4]  
EASTMAN PS, 1995, J ACQ IMMUN DEF SYND, V9, P264
[5]   SPECIFIC, SENSITIVE, AND RAPID ASSAY FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL MUTATIONS ASSOCIATED WITH RESISTANCE TO ZIDOVUDINE AND DIDANOSINE [J].
FRENKEL, LM ;
WAGNER, LE ;
ATWOOD, SM ;
CUMMINS, TJ ;
DEWHURST, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) :342-347
[6]   DETERMINATION OF HUMAN-IMMUNODEFICIENCY-VIRUS RNA IN PLASMA AND CELLULAR VIRAL-DNA GENOTYPIC ZIDOVUDINE RESISTANCE AND VIRAL LOAD DURING ZIDOVUDINE-DIDANOSINE COMBINATION THERAPY [J].
HOLODNIY, M ;
MOLE, L ;
MARGOLIS, D ;
MOSS, J ;
DONG, HL ;
BOYER, E ;
URDEA, M ;
KOLBERG, J ;
EASTMAN, S .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3510-3516
[7]   PREVALENCE AND CLINICAL-SIGNIFICANCE OF ZIDOVUDINE RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATED FROM PATIENTS AFTER LONG-TERM ZIDOVUDINE TREATMENT [J].
JAPOUR, AJ ;
WELLES, S ;
DAQUILA, RT ;
JOHNSON, VA ;
RICHMAN, DD ;
COOMBS, RW ;
REICHELDERFER, PS ;
KAHN, JO ;
CRUMPACKER, CS ;
KURITZKES, DR .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1172-1179
[8]   A MICROTITRE FORMAT POINT MUTATION ASSAY - APPLICATION TO THE DETECTION OF DRUG-RESISTANCE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED PATIENTS TREATED WITH ZIDOVUDINE [J].
KAYE, S ;
LOVEDAY, C ;
TEDDER, RS .
JOURNAL OF MEDICAL VIROLOGY, 1992, 37 (04) :241-246
[9]   ZIDOVUDINE RESISTANCE PREDICTED BY DIRECT DETECTION OF MUTATIONS IN DNA FROM HIV-INFECTED LYMPHOCYTES [J].
LARDER, BA ;
KELLAM, P ;
KEMP, SD .
AIDS, 1991, 5 (02) :137-144
[10]   MULTIPLE MUTATIONS IN HIV-1 REVERSE-TRANSCRIPTASE CONFER HIGH-LEVEL RESISTANCE TO ZIDOVUDINE (AZT) [J].
LARDER, BA ;
KEMP, SD .
SCIENCE, 1989, 246 (4934) :1155-1158